Smart Money Alert

Indegene Limited

New PositionBlock Deal

INDGNHealthcare Research, Analytics & TechnologyMarket Cap₹15K Cr

Deal value

₹25.04 Cr

Deal price

₹525.00

4.77 L

Trade date

6 Aug 2026

Since alert+10.8%₹554.45 → ₹614.60

Nifty 50+1.9%

Goldman Sachs

Foreign Investor

The move

Goldman Sachs bought 477,000 shares of Indegene Limited for ₹25.04 Cr at ₹525.00 apiece in a block deal.

About Indegene Limited

+ Follow Visit stock

A provider of analytics, technology, and specialized services to life science and healthcare organizations worldwide. Indegene delivers integrated solutions spanning commercial, medical, regulatory, and safety domains, combining data-driven insights with advanced technology platforms. The company serves pharmaceutical, biotech, and healthcare firms seeking to optimize operations, enhance decision-making, and improve market performance through evidence-based approaches and digital transformation.

About Goldman Sachs

+ Follow Visit investor

US-based global investment bank (USD 1.6 trillion in assets, USD 3 trillion+ in client AUM through Goldman Sachs Asset Management). India FPI activity covers proprietary, market-making, client flows and active asset management mandates in listed Indian equities.

Get the next move the moment it happens.

Follow Goldman Sachs and Indegene Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Indegene Limited shareholders Goldman Sachs's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Indegene Limited

SBI Mutual Fund

Direction, size, price and stake change for this move, with what it means for the company.

19 Oct 2026. Sign in to see this move